Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a software/maintenance update to the page. This update does not change study details or information presented.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a refreshed or republished version of the page.SummaryDifference0.0%

- Check23 days agoChange DetectedThe study's identifiers now include a reference to a 2018 U.S. NIH grant/contract, indicating NIH funding associated with this trial.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a newer version of the study details has been published.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page shows a new revision label 'Revision: v3.6.3', replacing the previous 'Revision: v3.6.0', indicating an updated page version. This update seems to be a routine template or system update rather than a change to study information.SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.